Directed Evolution of a Protein Container

An engineered protein container protects its bacterial host by efficient and selective encapsulation of a toxic protease. Confinement of enzymes in protein nanocompartments represents a potentially powerful strategy for controlling catalytic activity in cells. By using a simple electrostatically based tagging system for protein encapsulation, we successfully sequestered HIV protease, a toxic enzyme when produced cytoplasmically, within an engineered lumazine synthase capsid. The growth advantage resulting from protecting the Escherichia coli host from the protease enabled directed evolution of improved capsids. After four rounds of mutagenesis and selection, we obtained a variant with a 5- to 10-fold higher loading capacity than the starting capsid, which permitted efficient growth even at high intracellular concentrations of HIV protease. The superior properties of the evolved capsid can be ascribed to multiple mutations that increase the net negative charge on its luminal surface and thereby enhance engineered Coulombic interactions between host and guest. Such structures could be used for diverse biotechnological applications in living cells.

[1]  H. Saibil Chaperone machines in action. , 2008, Current opinion in structural biology.

[2]  S. Günther,et al.  Structural basis of enzyme encapsulation into a bacterial nanocompartment , 2008, Nature Structural &Molecular Biology.

[3]  Mato Knez,et al.  Biotemplate Synthesis of 3-nm Nickel and Cobalt Nanowires , 2003 .

[4]  T. Aida,et al.  Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles. , 2003 .

[5]  J. Rebek Simultaneous encapsulation: molecules held at close range. , 2005, Angewandte Chemie.

[6]  David V Schaffer,et al.  Molecular engineering of viral gene delivery vehicles. , 2008, Annual review of biomedical engineering.

[7]  A. Bacher,et al.  Substrate Channeling in the Lumazine Synthase/Riboflavin Synthase Complex of Bacillus subtilis(*) , 1995, The Journal of Biological Chemistry.

[8]  R. Nolte,et al.  Viruses and protein cages as nanocontainers and nanoreactors , 2009 .

[9]  L. Xing,et al.  Multiple assembly states of lumazine synthase: a model relating catalytic function and molecular assembly. , 2006, Journal of molecular biology.

[10]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[11]  A. Bacher,et al.  X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons. , 2001, Journal of molecular biology.

[12]  Donald Hilvert,et al.  A simple selection strategy for evolving highly efficient enzymes , 2007, Nature Biotechnology.

[13]  M. Young,et al.  Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. , 2005, Chemical communications.

[14]  S. Mann,et al.  Synthesis and Structure of an Iron(III) Sulfide-Ferritin Bioinorganic Nanocomposite , 1995, Science.

[15]  James K. Stoops,et al.  The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Young,et al.  Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.

[17]  A. Skalka,et al.  The retroviral enzymes. , 1994, Annual review of biochemistry.

[18]  M. Young,et al.  Protein Cage Constrained Synthesis of Ferrimagnetic Iron Oxide Nanoparticles , 2002 .

[19]  H. Kagawa,et al.  A self-assembling protein template for constrained synthesis and patterning of nanoparticle arrays. , 2005, Journal of the American Chemical Society.

[20]  A. Bacher,et al.  Synthesis of Nanophase Iron Oxide in Lumazine Synthase Capsids. , 2001, Angewandte Chemie.

[21]  M. Young,et al.  Synthetic control over magnetic moment and exchange bias in all-oxide materials encapsulated within a spherical protein cage. , 2007, Journal of the American Chemical Society.

[22]  J. Hess,et al.  Efficient Intracellular Delivery of a Protein and a Low Molecular Weight Substance via Recombinant Polyomavirus-like Particles* , 2004, Journal of Biological Chemistry.

[23]  T. Yeates,et al.  Protein-based organelles in bacteria: carboxysomes and related microcompartments , 2008, Nature Reviews Microbiology.

[24]  J. Ashby References and Notes , 1999 .

[25]  Todd O Yeates,et al.  Structure and Mechanisms of a Protein-Based Organelle in Escherichia coli , 2010, Science.

[26]  M. Botta,et al.  Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. , 2007, Nano letters.

[27]  Trevor Douglas,et al.  Biological Containers: Protein Cages as Multifunctional Nanoplatforms , 2007 .

[28]  Silvio Aime,et al.  Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. , 2002, Angewandte Chemie.

[29]  D. Hilvert,et al.  A simple tagging system for protein encapsulation. , 2006, Journal of the American Chemical Society.

[30]  Elizabeth C. Theil,et al.  Ferritins: dynamic management of biological iron and oxygen chemistry. , 2005, Accounts of chemical research.

[31]  Daniel Boehringer,et al.  Structure of Fungal Fatty Acid Synthase and Implications for Iterative Substrate Shuttling , 2007, Science.